MCRB CIK: 1609809

Seres Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.69
FY22:
−229
FY23:
−117
FY24:
−149
FY25:
1.12
Change from FY21 to FY25
millions USD
FY21:
64.1
FY22:
82.4
FY23:
10.6
FY24:
142
FY25:
−0.04
Change from FY21 to FY25
millions USD
FY21:
1.18
FY22:
130
FY23:
71.7
FY24:
−90.4
FY25:
13.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−2.88
FY22:
−239
FY23:
−125
FY24:
−149
FY25:
0.87

All amounts in millions USD Data source:SEC EDGAR